Pentecam gives accurate measurements

Article

The Pentecam is reliable in measuring superior and inferior anterior chamber angle (ACA) temporal and nasal ACA, anterior chamber volume (ACV) and anterior chamber depth (ACD).

The Pentecam is reliable in measuring superior and inferior anterior chamber angle (ACA) temporal and nasal ACA, anterior chamber volume (ACV) and anterior chamber depth (ACD).

Dr Gemma C.M. Rossi et al., University Eye Clinic of Pavia, IRCCS Policlinico San Matteo Foundation, Pavia, Italy, completed an observational, single-centre, cross-sectional investigation on 28 eyes with primary narrow-angle or primary angle-closure glaucoma and 36 controls.

All patients underwent gonioscopy and measurements for ACA, ACV and ACD. Receiver operating characteristics (ROC) curves analysis was used to assess the validity of Pentecam parameters.

According to the ROC analysis, there was a high discriminate power for all Pentecam measures and the chosen cutoff values enabled the correct identification of narrow angles.

Overall, the Pentecam is efficient in detecting occludable angles it is non-contact, meaning it provides parameters in a short time period, representing a possible screening tool.

The abstract can be viewed in the

latest European Journal of Ophthalmology

.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.